Equities analysts expect Syros Pharmaceuticals Inc (NASDAQ:SYRS) to report $720,000.00 in sales for the current fiscal quarter, Zacks reports. Four analysts have issued estimates for Syros Pharmaceuticals’ earnings. The lowest sales estimate is $350,000.00 and the highest is $1.75 million. The company is expected to issue its next quarterly earnings report on Wednesday, November 14th. […]
